510(k) Report

510(k) · Cleared

Recalled · Class II · 2026

Alere i Influenza A & B 2, Alere i Instrument, Alere i Influenza A & B Control Swab Kit

K171792510(k) TraditionalCleared Sep 29, 2017105-day reviewClass II21 CFR 866.3980Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Alere Scarborough, Inc. · OCC Respiratory Virus Panel Nucleic Acid Assay System

Cleared on Sep 29, 2017 as substantially equivalent to K163266 (Alere Scarborough, Inc., 2016) after a 105-day review. Its family tree reaches back 9 generations to 2008. 6 later devices descend from it. It has been recalled once.

Decided
Sep 29, 2017
Review
105 days
Class
Class II
Product code
OCC
Recalls
1
Predicates
1

Its longest line of descent runs back 9 generations to DEN070013 (2008). 12 ancestors in all, the oldest DEN060008 (2006). 6 later devices descend from it, 2 citing it directly.

  1. Root · 9 generations backDEN070013 ID-Tag Respiratory Viral PanelLuminex Molecular Diagnostics, Inc. · 2008
  2. 5 generations between
  3. 3 generations backK141520 Alere I Influenza a & BAlere Scarborough, Inc D/B/A Binax, Inc. · 2014 · Recalled
  4. 2 generations backK151464 Alere i Influenza A & B, Alere i Instrument, Alere i Influenza A & B…Alere Scarborough, Inc. · 2015
  5. 1 generation backK163266 Alere i Influenza A & B, Alere i Influenza A & B Control Swab Kit…Alere Scarborough, Inc. · 2016
  6. This deviceK171792 Alere i Influenza A & B 2, Alere i Instrument, Alere i Influenza A &…Alere Scarborough, Inc. · 2017
  7. Descendant · cites it directly · 3 of its ownK173932 Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i…Alere Scarborough, Inc. · 2018
  8. Descendant · cites it directly · 2 of its ownK220801 ID Now Instrument, ID Now Influenza A & B 2, ID NOW Strep A 2Abbott Diagnostics Scarborough, Inc. · 2022
  9. Descendant · 2 generations on · 1 of its ownK232775 ID NOW Influenza A & B 2Abbott Diagnostics Scarborough, Inc. · 2023 · Recalled
  10. Descendant · 2 generations on · 1 of its ownK190204 ID NOW Influenza A & B 2Alere Scarborough, Inc. · 2019
  11. Descendant · 2 generations on · 0 of its ownK262747 ID NOW Influenza A & B 2; ID NOW RSV; ID NOW Strep A 2; ID NOW…Abbott Diagnostics Scarborough, Inc. · 2026
Show all 9 generations
  1. Root · 9 generations backDEN070013 ID-Tag Respiratory Viral PanelLuminex Molecular Diagnostics, Inc. · 2008
  2. 8 generations backK081483 Xtag Respiratory Viral PanelLuminex Molecular Diagnostics, Inc. · 2008 · Recalled
  3. 7 generations backK091667 Xtag Respiratory Viral Panel, Models I019A0110, I019C011, I019D0112…Luminex Molecular Diagnostics, Inc. · 2009 · Recalled
  4. 6 generations backK100148 Simplexa Influenza a H1N1 (2009) Model MOL2500Focus Diagnostics, Inc. · 2010
  5. 5 generations backK103766 Xpert Flu, Genexpert DX Systems, Genexpert Infinity System…Cepheid · 2011 · Recalled
  6. 4 generations backK111387 Liat (TM) Influenza a / B Assay, Liat (TM) AnalyzerIquum, Inc. · 2011 · Recalled
  7. 3 generations backK141520 Alere I Influenza a & BAlere Scarborough, Inc D/B/A Binax, Inc. · 2014 · Recalled
  8. 2 generations backK151464 Alere i Influenza A & B, Alere i Instrument, Alere i Influenza A & B…Alere Scarborough, Inc. · 2015
  9. 1 generation backK163266 Alere i Influenza A & B, Alere i Influenza A & B Control Swab Kit…Alere Scarborough, Inc. · 2016
  10. This deviceK171792 Alere i Influenza A & B 2, Alere i Instrument, Alere i Influenza A &…Alere Scarborough, Inc. · 2017

Showing 5 of 6 descendants. See all descendants

Descendants cleared per year

2018: 12019: 22022: 12023: 12026: 1
2018high 2 (2019) · low 0 (2020)2026

Most influential descendants

Showing 5 of 6 · See all
  • K173932Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2Alere Scarborough, Inc. · 2018 · cites it directly3descendants
  • K220801ID Now Instrument, ID Now Influenza A & B 2, ID NOW Strep A 2Abbott Diagnostics Scarborough, Inc. · 2022 · cites it directly2descendants
  • K232775ID NOW Influenza A & B 2Abbott Diagnostics Scarborough, Inc. · 2023 · 2 generations on1descendant
  • K190204ID NOW Influenza A & B 2Alere Scarborough, Inc. · 2019 · 2 generations on1descendant
  • K262747ID NOW Influenza A & B 2; ID NOW RSV; ID NOW Strep A 2; ID NOW COVID-19 2.0Abbott Diagnostics Scarborough, Inc. · 2026 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9DEN070013ID-Tag Respiratory Viral PanelLuminex Molecular Diagnostics, Inc.2008—
−8K081483Xtag Respiratory Viral PanelLuminex Molecular Diagnostics, Inc.20081
−7K091667Xtag Respiratory Viral Panel, Models I019A0110, I019C011, I019D0112…Luminex Molecular Diagnostics, Inc.20091
−6K100148Simplexa Influenza a H1N1 (2009) Model MOL2500Focus Diagnostics, Inc.2010—
−5K103766Xpert Flu, Genexpert DX Systems, Genexpert Infinity System, Genexpert System…Cepheid20111
−4K111387Liat (TM) Influenza a / B Assay, Liat (TM) AnalyzerIquum, Inc.20114
−3K141520Alere I Influenza a & BAlere Scarborough, Inc D/B/A Binax, Inc.20143
−2K151464Alere i Influenza A & B, Alere i Instrument, Alere i Influenza A & B Control…Alere Scarborough, Inc.2015—
−1K163266Alere i Influenza A & B, Alere i Influenza A & B Control Swab Kit, Alere i…Alere Scarborough, Inc.2016—
0 (this device)K171792Alere i Influenza A & B 2, Alere i Instrument, Alere i Influenza A & B Control…Alere Scarborough, Inc.2017—
+1K173932Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2Alere Scarborough, Inc.2018—
+1K220801ID Now Instrument, ID Now Influenza A & B 2, ID NOW Strep A 2Abbott Diagnostics Scarborough, Inc.2022—
+2K232775ID NOW Influenza A & B 2Abbott Diagnostics Scarborough, Inc.20232
+2K190204ID NOW Influenza A & B 2Alere Scarborough, Inc.2019—
+2K262747ID NOW Influenza A & B 2; ID NOW RSV; ID NOW Strep A 2; ID NOW COVID-19 2.0Abbott Diagnostics Scarborough, Inc.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200610
200820

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201810
201920
202210
202310
202610
FIG. 1 — Lineage of K171792, 2008–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OCC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OCC device

  1. #1 K262747 ID NOW Influenza A & B 2; ID NOW RSV; ID NOW…score 15.2 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K163266Alere i Influenza A & B, Alere i Influenza A & B Control Swab Kit, Alere i Instrument
Summary page 4
…cal Multiplex Test Systems (per 21 CFR 862.2570) CLASSIFICATION Class II PRODUCT CODE OCC, OZE, OOI PANEL Microbiology (83) PREDICATE DEVICE Alere™ i Influenza A & B K163266 Alere™ i Influenza A & B 2 Page 1 510(k) Notification – Con…
Alere Scarborough, Inc.2016—

Also cleared against K163266: 1 other device →

What descends from it? (6)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K173932Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2Alere Scarborough, Inc.20183
K220801ID Now Instrument, ID Now Influenza A & B 2, ID NOW Strep A 2Abbott Diagnostics Scarborough, Inc.20222

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Feb 9, 2026Class IIZ-1565-2026Under Investigation by firmIt was confirmed that the impacted lot has a higher occurrence of invalid rates when compared to the product Instructions for Use.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 9 years and passes through 6 companies; a new generation was cleared every 11 months on median.
  • 5 of the 12 ancestors have a recall of any class.
  • Of its descendants, K173932 (Alere Scarborough, Inc., 2018) has gone furthest, with 3 descendants of its own.
  • 1 other device also cites its predicate K163266.

How does its category compare?

All OCC devices

OCC Respiratory Virus Panel Nucleic Acid Assay System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · OCC

1in 2024

2008: 42009: 62010: 22011: 92012: 62013: 62014: 42015: 82016: 72017: 102018: 42019: 52020: 22021: 12022: 12023: 22024: 12026 (partial year): 3
2007high 10 (2017) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OCC

31in 2019

2008: 28 days median2009: 24 days median2011: 82 days median2012: 125 days median2013: 79 days median2014: 94 days median2015: 85 days median2016: 92 days median2017: 136 days median2018: 134 days median2019: 31 days median2026 (partial year): 130 days median
2007high 136 (2017) · low 24 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OCC

1in 2024

2014: 12018: 12019: 12024: 1
2007high 1 (2014) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OCC

2in 2025

2011: 22012: 12014: 522015: 12016: 362017: 12018: 12019: 22020: 172021: 6862022: 22023: 12024: 32025: 2
2007high 686 (2021) · low 0 (2007)2025

MAUDE reports naming product code OCC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
200842800
200962400
20102—00
201198202
2012612501
201367900
2014494152
201588501
2016792036
20171013601
2018413411
201953112
20202—017
20211—0686
20221—02
20232—01
20241—13
20250—02
202631300—

What is it indicated for?

The Alere i Influenza A & B 2 assay performed on the Alere i Instrument is a rapid molecular in vitro diagnostic test utilizing an isothermal nucleic acid amplification technology for the qualitative detection and discrimination of influenza A and B viral RNA in direct nasal or nasopharyngeal swabs and nasal or nasopharyngeal swabs eluted in viral transport media from patients with signs and symptoms of respiratory infection. It is intended for use as an…

Read the full statement (239 words)

The Alere i Influenza A & B 2 assay performed on the Alere i Instrument is a rapid molecular in vitro diagnostic test utilizing an isothermal nucleic acid amplification technology for the qualitative detection and discrimination of influenza A and B viral RNA in direct nasal or nasopharyngeal swabs and nasal or nasopharyngeal swabs eluted in viral transport media from patients with signs and symptoms of respiratory infection. It is intended for use as an aid in the differential diagnosis of influenza A and B viral infections in humans in conjunction with clinical and epidemiological risk factors. The assay is not intended to detect the presence of influenza C virus.

Negative results do not preclude influenza virus infection and should not be used as the sole basis for diagnosis, treatment or other patient management decisions.

Performance characteristics for influenza A were established during the 2016-2017 influenza season when influenza A/H3 and A/H1N1 pandemic were the predominant influenza A viruses in circulation. When other influenza A viruses are emerging, performance characteristics may vary.

If infection with a novel influenza A virus is suspected based on current clinical and epidemiological screening criteria recommended by public health authorities, specimens should be collected with appropriate infection control precautions for novel virulent Influenza viruses and sent to state or local health department for testing. Viral culture should not be attempted in cases unless a BSL 3+ facility is available to receive and culture specimens.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K171792: Alere i Influenza A & B 2, Alere i Instrument, Alere i Influenza A & B Control Swab Kit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K171792

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026